Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000116445 | SCV000150370 | benign | not specified | 2013-08-16 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000116445 | SCV000225063 | benign | not specified | 2015-01-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000116445 | SCV000313960 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000555414 | SCV000640203 | benign | Kufor-Rakeb syndrome; Autosomal recessive spastic paraplegia type 78 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000675905 | SCV000841010 | benign | not provided | 2017-08-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312035 | SCV000846546 | benign | Inborn genetic diseases | 2016-04-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV001099191 | SCV001255621 | likely benign | Kufor-Rakeb syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000675905 | SCV001832223 | benign | not provided | 2019-10-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27294386, 19705361, 22743658, 22995991) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000116445 | SCV002051006 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000675905 | SCV002496462 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | ATP13A2: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV000675905 | SCV005259382 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000675905 | SCV000801632 | uncertain significance | not provided | 2017-11-13 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000675905 | SCV001799294 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000675905 | SCV001808482 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000675905 | SCV001972657 | likely benign | not provided | no assertion criteria provided | clinical testing |